Skip to main content
Signal8

Dogwood Therapeutics, Inc. (DWTX) Form S-3 — Oct 30, 2026

$DWTXForm S-3Filed Oct 30, 2026, 4:02 PM ET0001104659-26-120650Original filing

Dogwood Therapeutics filed an S-3 registering for resale 4,098,360 shares held by Sealbond Limited, its controlling stockholder, which bought the shares at $1.22 per share in a $5.0 million private placement that closed October 26, 2026. The company receives no proceeds from any resale; the registration satisfies obligations under an October 19, 2026 Registration Rights Agreement. Sealbond beneficially owns approximately 67.8% of the 38.2 million shares outstanding (57.1% if all registered shares are sold), and affiliate Conjoint, Inc. holds about 7.4%, giving the CK Life Sciences group effective control of the company.

Key figures

Gross Proceeds
$5.0 million (private placement; company receives no resale proceeds)
Offering Price
1.22
Shares Offered
4098360
Shares Outstanding
38227913
Warrant shares
4386892
Conjoint ownership pct
7.4
Option shares issuable
1846227
Sealbond ownership pct
67.8
Share price oct28 2026
1.24
Warrant avg exercise price
3.28
Sealbond ownership after pct
57.1
Potential warrant proceeds usd
14400000

AI analysis

Red flags6 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    Dogwood Therapeutics, Inc. (DWTX) Form S-3 — Oct 30, 2026: AI Analysis | Signal8